• Profile
Close

Clinical significance of anti-NOR90 antibodies in systemic sclerosis and idiopathic interstitial pneumonia

Rheumatology Jul 29, 2021

Yamashita Y, Yamano Y, Muro Y, et al. - This study was intended to construct an enzyme-linked immunosorbent assay (ELISA) for measuring them to investigate the clinical features of patients with anti-NOR90 antibodies. Researchers included serum samples from 1,252 patients with various conditions from Nagoya University Hospital and 244 patients with idiopathic interstitial pneumonia (IIP) from Tosei General Hospital. They further evaluated anti-NOR90 antibodies by an ELISA using the recombinant protein produced by in vitro transcription/translation. ELISA is useful for their detection, although anti-NOR90 antibodies are rarely found in clinics. There is a need for further studies to confirm the association of anti-NOR90 antibodies with ILD and cancer in systemic sclerosis and IIP patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay